Showing results (451-460 of 3,371) with videos related to
Sort By:
Pageof 338
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1992
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzaeM S Barrett, R N JonesDiagnostic Microbiology and Infectious Disease|August 1, 1992
In vitro activity of CP-74667 compared with four other fluoroquinolonesR N Jones, M E ErwinDiagnostic Microbiology and Infectious Disease|February 15, 2001
In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methodsD J Biedenbach, R N JonesDiagnostic Microbiology and Infectious Disease|July 25, 2000
Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study GroupR N Jones, M E ErwinDiagnostic Microbiology and Infectious Disease|March 27, 1999
Spectrum and antimicrobial activity of alexomycin (PNU-82, 127), a peptide compound projected for use in animal healthS A Marshall, R N JonesEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1992
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218D M Johnson, R N JonesPostgraduate Medical Journal|January 1, 1983
The antimicrobial activity of cephalexin against old and new pathogensR N Jones, D A PrestonJournal of Chemotherapy (Florence, Italy)|February 1, 1994
Post-antibiotic effect of FK-037 and biapenem tested against five bacterial speciesA K Houston, R N JonesDiagnostic Microbiology and Infectious Disease|May 1, 1989
Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococciR N Jones, R V GardinerDiagnostic Microbiology and Infectious Disease|January 1, 1997
Antimicrobial activity of RU-66647, a new ketolideR N Jones, D J BiedenbachPageof 338